At Stratenym, we understand the challenges you face in establishing the value of your product in the marketplace. As experts, we know how to anticipate and overcome them. With decades of combined industry experience, our team has a proven track record of success in medical communications.
Stratenym consultants hold advanced or professional degrees (MSc, PhD, PharmD, MD) in relevant scientific or medical fields, as well as memberships with:
W. Mark Roberts
Vice President, Medical Communications
BSc (Hons) & MSc, University of British Columbia;
MA & PhD, Princeton University
Mark combines an editor’s eye for detail with the big-picture insights he has gained over 17 years in the field of health economics and outcomes research. Mark leverages his extensive experience as a manager of content-development teams and as a hands-on medical writer and editor to ensure the high quality of our deliverables.
Successfully transitioning from academia to industry in 2003, Mark has built deep experience in developing medical communications in a broad range of therapeutic areas, with a strong focus on orphan indications. He is an expert on effective presentation of research findings, including for such specialized topics as cost-effectiveness analysis, retrospective database analysis, and patient-reported outcomes. Over his long career in the field, he has supported the development of global value dossiers, strategy documents to help companies differentiate their products from the competition, articles for peer-reviewed biomedical journals, pharmacoeconomic model reports, and conference abstracts, posters and slide decks.
From 2006–2009, Mark was the Managing Editor at IC Axon, where he supervised the medical writer team creating content for innovative sales training for clients in the pharmaceutical industry. Prior to this position, Mark was a Senior Research Application Associate at BioMedCom Consultants, where he developed projects for clients in industry and academia. He has also taught courses in biostatistics and experimental methods at McGill University.
Vice President, Strategy and Value
BSc, Dalhousie University;
MSc, McGill University
Sabrina provides hands-on strategic guidance on Stratenym projects with a focus on highlighting product value. With 15+ years of experience in developing communications for diverse audiences, including payers, physicians, researchers, and pharmaceutical executives, she is an expert at extracting and conveying compelling value messages from clinical data.
Sabrina has more than 15 years of experience in medical communications. Over the span of her career, she has worked with a diverse group of Fortune 500 pharma companies, biotech startups, non-profit organizations, and academia. At Stratenym, she provides strategic guidance on medical communications and market access initiatives, as well as directly developing scientific content.
Sabrina has experience in several therapeutic areas, including oncology, infectious disease and immunology, gastroenterology, cardiology, rheumatology, endocrinology, neurology, and hematology. Her past projects include international disease awareness campaigns, global value dossiers, payer value messages, HTA and reimbursement submissions, conference abstracts and presentations, systematic literature reviews, as well as comparative effectiveness research and targeted research on patient-reported outcomes. With expertise in value-driven and evidence-based communications, her work has led to several HTA agency recommendations for product reimbursement.
Prior to Stratenym, Sabrina held senior roles at two international communications companies where she led teams on several high-profile sales training, disease awareness, and market access initiatives.
Vice President, Operations
BA, McGill University;
MBA, University of Illinois;
Alexandra runs Stratenym’s day-to-day operations including project management, marketing, legal, administration and finance. She brings 15+ years of experience in digital marketing, technology product design, business consulting and professional services delivery across industries.
Alexandra brings 15+ years of experience in professional services delivery, business consulting, digital marketing, and technology product design that spans industries.
Over her career, she has led teams large and small in previous roles at Berkeley Payments (financial services), Publicis Worldwide (advertising & communications), Nurun (web and product strategy & design), Sapient/Razorfish (web development), K2 Digital/Klick (marketing technology), Mate1 (e-Commerce), IC Axon (pharmaceutical sales force training), VIA Rail (e-Learning), and McGill University (IT training & support).
She has also been privileged to work with other distinguished clients through her own consulting practice.
Alexandra’s mission is to solve business problems through technology and innovation, seeking maximum efficiency and effectiveness.
She believes in strong yet flexible project governance and is an advocate of iterative, agile program management.
PhD, Uni of Strathclyde; MWC (AMWA)
Georghia uses her natural talent for content development to successfully distill and communicate complex medical evidence on Stratenym projects.
She brings extensive healthcare knowledge and 10+ years of experience writing for different audiences in the fields of cardiology, endocrinology, dermatology, oncology, gastroenterology, hematology, and rheumatology.
PhD, University of Calgary
Kim brings over 10+ years of experience in delivering high-quality targeted communications to the pharmaceutical industry for patient, clinician, and health authority audiences.
Kim draws upon her knowledge, professionalism, and integrity to write inspiring evidence-based communications that make a positive impact on the lives of patients.
LLM, Staffordshire University, UK
Maria has over 15 years of experience in advising on healthcare policy, forecasting, and value strategy for the pharmaceutical industry. She is an expert in identifying market and pricing opportunities for new or currently commercialized pharmaceutical products.
Her specialities include payer research, evidence generation, value messaging, product testing, and analysis of market/competitor environment.
PhD, University of Cambridge
Fiona combines 10+ years in academic/pharmaceutical research with 10+ years creating tailored medical communications solutions for diverse audiences.
Her areas of expertise include gene therapy, hematology, oncology, developmental neurobiology, RNA biochemistry, and more. Fiona is passionate about empowerment through knowledge.
PhD, McGill University
Chris has over 14 years of international Medical Communications experience, including Decision Support Project Management, and Medical Writing/editing for Market Access support.
Chris has a passion for conveying how the latest advances in biomedical and clinical research help improve patient outcomes and deliver healthcare business efficiencies.
PhD, University of Waterloo
Julia is an experienced scientific consultant and medical writer, with 13 years of medical writing experience. She has experience in many therapeutic areas, including neurology, oncology, dermatology, cardiology, and immunology.
She leverages her years of client needs assessments and rigorous scientific training to produce top-quality deliverables for our clients.
PhD, University of Cambridge
Susan is an experienced medical writer and consultant with 10+ years delivering strategic evidence-based communications.
Susan is well versed across numerous therapeutic areas including, but not limited to, neurology, cardiology, oncology, nephrology, and gastroenterology.
MSc, McGill University
Angela has 10+ years of experience as a medical writer, leveraging her 10+ years of experience in academic and pharmaceutical research to prepare content for a wide range of clients.
Her areas of expertise include psychiatric disorders, infectious diseases, oncology, immunology, metabolic disorders and inflammatory diseases.
PhD, Queen's University
Ruby is an experienced scientific writer and editor with 6 years of research experience. She has broad expertise in many therapeutic areas including oncology, regenerative medicine, nanotechnology, and more.
She leverages her scientific acumen and client experience to produce high-quality deliverables. She is a firm believer of providing accurate, clear, and concise scientific information.
Stratenym is proud to recommend and collaborate with the following companies to offer full-service solutions to our clients: